G1 is the major APOL1 risk allele for hypertension-attributed nephropathy in Central Africa

Clinical Kidney Journal

Volumn 12, Issue 2, 2018, Pages 188-195

  Sumaili, Ernest K ^a   Shemer, Revital ^b   Kruzel Davila, Etty ^b,c   Cohen, Eric P ^d   Mutantu, Pierre N ^a   Bukabau, Justine B ^a   Makulo, Jean Robert R ^a   Mokoli, Vieux M ^a   Luse, Jeannine L ^e   Pakasa, Nestor M ^f   Cavalier, Etienne ^g   Wumba, Roger D ^f   Reiner Benaim, Anat ^h   Boner, Geoffrey ⁱ   Lifschitz, Meyer ^j   Nseka, Nazaire M ^a   Skorecki, Karl ^b,c   Wasser, Walter G ^c,k  

^a Clinique Universitaire de Kinshasa   (Congo)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c Division of Nephrology   (Israel)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e Kinshasa Provincial General Hospital   (Democratic Republic Congo)

^f UNIVERSITY OF KINSHASA   (Congo)

^g UNIVERSITY OF LIÈGE   (Belgium)

^h Rambam Health Care Campus   (Israel)

ⁱ TEL AVIV UNIVERSITY   (Israel)

^j SHAARE ZEDEK MEDICAL CENTER   (Israel)

^k Mayaney Hayeshua Medical Center   (Israel)

more..

Author keywords

APOL1 risk variants; CKD; Hypertension; Kinshasa; Trypanosoma brucei gambiense

Indexed keywords

APOLIPOPROTEIN L1; APOPROTEIN L1 G1; GENOMIC DNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CONGOLESE (KINSHASA); CONTROLLED STUDY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; HYPERTENSION; INHERITANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SELECTIVE SWEEP; SINGLE NUCLEOTIDE POLYMORPHISM; TRYPANOSOMA BRUCEI GAMBIENSE;

EID: 85068574294     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfy073     Document Type: Article

References (29)

1. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic APOL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845
2. Tzur S, Rosset S, Shemer R et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010; 128: 345-350
3. Kopp JB, Nelson GW, Sampath K et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 2011; 22: 2129-2137
4. Kasembeli AN, Duarte R, Ramsay M et al. APOL1 risk variants are strongly associated with HIV-associated nephropathy in Black South Africans. J Am Soc Nephrol 2015; 26: 2882-2890
5. Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P et al. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 2003; 422: 83-87
6. Osafo C, Raji YR, Olanrewaju T et al. Genomic approaches to the burden of kidney disease in Sub-Saharan Africa: The Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network. Kidney Int 2016; 90: 2-5
7. Thomson R, Genovese G, Canon C et al. Evolution of the primate trypanolytic factor APOL1. Proc Natl Acad Sci USA 2014; 111: E2130-E2139
8. Cooper A, Ilboudo H, Alibu VP et al. APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis. Elife 2017; 6; e25461: 1-18
9. KaboréJW, Ilboudo H, Noyes H et al. Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea. PLoS Negl Trop Dis 2017; 11: E0005833
10. Franco JR, Cecchi G, Priotto G et al. Monitoring the elimination of human African trypanosomiasis: Update to 2014. PLoS Negl Trop Dis 2017; 11: E0005585
11. Sumaili EK, Cohen EP, Zinga CV et al. High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol 2009; 10: 18
12. Nlandu Y, Lepira F, Makulo JR et al. Reverse epidemiology of elevated blood pressure among chronic hemodialysis black patients with stroke: A historical cohort study. BMC Nephrol 2017; 18: 277
13. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252
14. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann InternMed 2009; 150: 604-612
15. Omuse G, Maina D, Mwangi J et al. Comparison of equations for estimating glomerular filtration rate in screening for chronic kidney disease in asymptomatic black Africans: A cross sectional study. BMC Nephrol 2017; 18: 369
16. Bukabau JB, Sumaili EK, Cavalier E et al. Performance of glomerular filtration rate estimation equations in Congolese healthy adults: The inopportunity of the ethnic correction. PLoS One 2018; 13: E0193384
17. Levey AS, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: Approaches and initiatives-A position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72: 247-259
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215
19. Ulasi II, Tzur S, Wasser WG et al. High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria. Nephron Clin Pract 2013; 123: 123-128
20. Limou S, Nelson GW, Lecordier L et al. Sequencing rare and common APOL1 coding variants to determine kidney disease risk. Kidney Int 2015; 88: 754-763
21. Hawkins GA, Friedman DJ, Lu L et al. Re-sequencing of the APOL1-APOL4 and MYH9 gene regions in African Americans does not identify additional risks for CKD progression. Am J Nephrol 2015; 42: 99-106
22. Skorecki KL, Wasser WG. Hypertension-misattributed kidney disease in African Americans. Kidney Int 2013; 83: 6-9
23. Alves I, Coelho M, Gignoux C et al. Genetic homogeneity across Bantu-speaking groups from Mozambique and Angola challenges early split scenarios between East and West Bantu populations. Hum Biol 2011; 83: 13-38
24. Nielsen R, Akey JM, JakobssonMet al. Tracing the peopling of the world through genomics. Nature 2017; 541: 302
25. Samanovic M, Molina-Portela MP, Chessler AD et al. Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection. PLoS Pathog 2009; 5: E1000276
26. Taylor HE, Khatua AK, Popik W. The innate immune factor apolipoprotein L1 restricts HIV-1 infection. J Virol 2014; 88: 592-603
27. Tzur S, Rosset S, Skorecki K et al. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease. Nephrol Dial Transplant 2012; 27: 1498-1505
28. Kanji Z, Powe CE, Wenger JB et al. Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol 2011; 22: 2091-2097
29. Karczewski KJ, Weisburd B, Thomas B et al. The ExAC browser: Displaying reference data information from over 60 000 exomes. Nucleic Acids Res 2017; 45: D840-D845